MDxHealth SA
MDXH Healthcare Diagnostics & Research
MDxHealth SA’s revenue for fiscal 2025 (year ended December 2025) was $107.9 million, up 19.8% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS fell 15.8%, free cash flow fell 200.2% and total debt rose 26.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow MDXH
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more quarters Free account |
(2.64) | (5.26) | (7.30) | (7.12) |
Depreciation & Amortization |
2.25 | 2.44 | 2.39 | 2.39 | |
Non Cash Items (Other) |
(0.21) | 0.61 | 0.57 | 2.36 | |
Accounts Receivable Change |
0.55 | 2.86 | 0.33 | (1.02) | |
Change in inventories |
(1.07) | (0.55) | (0.63) | 0.03 | |
Accounts Payable Change |
2.78 | 0.28 | 3.15 | (2.50) | |
Operating Cash Flow |
1.66 | 0.38 | (1.49) | (5.85) | |
Capital expenditures |
(0.26) | (0.05) | (0.36) | (0.04) | |
Net Aquisitions |
— | — | — | (7.78) | |
Other investing activities |
(20.17) | 1.85 | (0.14) | 0.16 | |
Investing cash flow |
(0.77) | 1.79 | (0.50) | (7.66) | |
Repayment/Issuance of Debt (Net) |
(0.54) | (0.75) | 18.71 | (0.70) | |
Other financial activities |
(1.14) | (4.40) | (2.59) | (9.74) | |
Financing cash flow |
(1.68) | (5.15) | 16.12 | (10.44) | |
Exchange Rate Adjustment |
0.00 | 0.00 | 0.00 | 0.00 | |
Change in Cash |
(0.80) | (2.98) | 14.12 | (23.95) | |
Beginning Cash |
0.00 | 0.00 | 29.03 | 0.00 | |
Ending Cash |
(0.80) | (2.98) | 43.15 | (23.95) | |
Stock Based Compensation |
0.45 | 0.69 | 0.56 | 0.61 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
2.26 | 2.59 | 2.85 | (3.48) |